Web Content Display
- 17.2 Guanylate Cyclase (GC) Stimulators
- 2.2 Tadalafil Tablets for Once Daily Use for Erectile Dysfunction
- 1.1 Erectile Dysfunction
- 5.1 Cardiovascular
- 7.2 Potential for Other Drugs to Affect Tadalafil Tablets
- 2.1 Tadalafil Tablets for Use as Needed for Erectile Dysfunction
- In case of emergency/overdose
We see FEM certificate as a reward for our determined and continuous efforts in this field. Brochure HEALING THE LIVES, HEALING THE FUTURE THAT’S WHAT WE DO.Turkish pharmaceutical industry leader Abdi Ibrahim s journey began in 1912.In addition to its partnerships with more than 30 licensing firms across the globe, Abdi Ibrahim develops its own products with 250 brands and 500 products.Abdi Ibrahim has subsidiaries operating in 17 countries outside Turkey, exports to more than 70 countries from the European Union to Canada, North Africa to Asia and generates the highest employment rate in the Turkish pharmaceutical industry with 5500 qualified employees. News R&D Award to Abdi İbrahim in 5 CategoriesAbdi İbrahim, the uninterrupted leader of the Turkish pharmaceutical industry for 21 years, received awards in 5 categories at the Crystal Mortar Awards organized by the Chemists' Association.Acting for 111 years with the mission of improving life, Abdi İbrahim received awards in 5 categories at the Crystal Mortar Awards, given within the scope of the 11th International Pharmaceutical Chemistry Congress for its R&D studies and investments.
- Tadalafil 5mg has a duration of action up to 36 hours.
- It can improve spontaneous sexual activity.
- Dosage adjustments may be necessary for certain health conditions.
On the opening day of the 11th International Pharmaceutical Chemistry Congress organized by the Chemists' Association in Antalya this year, the R&D activities of pharmaceutical companies were awarded in 7 categories.
| Storage Aspect | Condition | Notes |
|---|---|---|
| Temperature | Below 30°C (86°F) | Keep away from heat and moisture |
| Light Exposure | Store in a dark place | Protect from light |
| Keep Out of Reach | Children and pets | Safety precaution |
| Packaging | Original container | Keep sealed and intact |
| Expiry Date | Refer to packaging | Do not use past expiration date |
Abdi İbrahim won awards in 5 categories, including the “Pharmaceutical Company with the Most R&D Investments” category. News Abdi İbrahim Foundation House of Kindness Open NowProviding accommodation for children and their families who come to Istanbul for cancer treatmentAbdi İbrahim, the leader of the Turkish pharmaceutical industry, has initiated a social project for children undergoing cancer treatment and their families. Abdi İbrahim Foundation House of Kindness, which provides accommodation for children who come to İstanbul for cancer treatment but face difficulties staying due to economic reasons, has opened its doors in Fatih, İstanbul. Speaking at the opening ceremony, Nesrin Barut Esirtgen, Deputy Chairperson of Abdi İbrahim and Chairperson of the Board of Trustees of the Abdi İbrahim Foundation, said: “Taking into account the accommodation needs of our children and their relatives who come to Istanbul for treatment, we realized the House of Kindness project to be part of the solution.
- Tadalafil 5mg may interact with other medications.
- Follow prescribed instructions for safe use.
- Misuse can lead to serious health risks or side effects.
We strongly believe that kindness and the passion for healing are contagious. Our House of Kindness is a reflection of this belief and will.” D.. News Abdi İbrahim and GSK Türkiye Make Major Investment for Domestic Production of Respiratory MedicineThe Sterile Inhalation Facility, jointly developed by Abdi İbrahim and GSK Türkiye in collaboration with the Investment Office of the Presidency of the Republic of Türkiye, commences operations.The facility, built with an investment of TRY 340 million, will enable Türkiye to benefit from the advanced ‘nebule’ technology, which is used in the treatment of respiratory diseases. The facility is the first in the world capable of manufacturing the complete range of GSK’s nebule portfolio. News The First "Mab" Biotech Pharmaceutical to be Locally Manufactured in Türkiye Will Bear the Mark of AbdiBio from the Cellular LevelANOTHER FIRST FROM ABDİ İBRAHİMAbdi İbrahim, the leader in the Turkish pharmaceutical industry for 21 years, continues its unwavering commitment to investing in biotechnology. Abdi İbrahim has announced a technology transfer agreement with the Spanish biosimilar developer, mAbxience, which is among the world’s leading companies in the field.Accordingly, a currently tadalafil for premature ejaculation imported cancer drug will now be manufactured by AbdiBio.
17.2 Guanylate Cyclase (GC) Stimulators
What are the serious side effects of tadalafil?
Nezih Barut, Chairman of Abdi İbrahim, noted the technology transfer’s significance as the first “cell-to-end product” biotech pharmaceutical in Türkiye. News Türkiye's Leading Pharmaceutical Company Expands its Portfolio and Presence in Consumer HealthABDİ İBRAHİM STRIKES DEAL WITH ARONPHARMAAbdi İbrahim, Türkiye's leading pharmaceutical company and a strong player in consumer health products, is collaborating with Aronpharma, a key European company specializing in innovative food supplements for their innovative brand Berroxin.Abdi İbrahim has acquired sales and distribution rights in Türkiye for products that help support the immune system under the Berroxin brand of Aronpharma, which offers innovative food supplement products. The portfolio will be launched in the Turkish market starting in 2023 with the assurance of Abdi İbrahim.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 20mg | 60 + 6 Pills | 117.76€ 112.15€ | |
| Cialis Generic | 10mg | 20 Pills | 48.23€ 45.93€ | |
| Cialis Generic | 20mg | 10 Pills | 31.49€ 29.99€ | |
| Tadalista Super Active | 20mg | 120 + 16 Pills | 382.15€ 363.95€ | |
| Cialis Generic | 10mg | 180 + 8 Pills | 236.88€ 225.60€ | |
| Cialis Generic | 20mg | 90 + 6 Pills | 154.71€ 147.34€ | |
| Cialis Generic | 20mg | 30 + 4 Pills | 68.05€ 64.81€ | |
| Cialis Generic | 10mg | 90 + 6 Pills | 146.17€ 139.21€ | |
| Cialis Generic | 60mg | 90 + 6 Pills | 196.67€ 187.30€ | |
| Cialis Generic | 2.5mg | 360 + 10 Pills | 260.03€ 247.65€ | |
| Cialis Generic | 40mg | 20 Pills | 59.47€ 56.64€ | |
| Tadalista Super Active | 20mg | 30 + 6 Pills | 128.09€ 121.99€ | |
| Cialis Generic | 5mg | 30 + 4 Pills | 53.56€ 51.01€ | |
| Tadalista Super Active | 20mg | 270 + 30 Pills | 661.49€ 629.99€ | |
| Cialis Generic | 2.5mg | 120 + 6 Pills | 128.93€ 122.79€ | |
| Cialis Generic | 40mg | 360 + 10 Pills | 477.87€ 455.11€ |
News Abdi İbrahim Secures a Coveted Spot as the First Turkish Pharmaceutical Company on the CDP's Climate A ListThe unrivalled leader in the Turkish pharmaceutical industry for 22 years, Abdi İbrahim attains a noteworthy achievement by earning a coveted spot on the Climate A list within the 2023 Carbon Disclosure Project (CDP) Climate Change Program. For 112 years marked by a passion for progress, Abdi İbrahim has actively embraced the green transformation by diligently integrating environmental considerations into its business models. Aligned with the ambitious 1.5°C target of the Paris Agreement, its greenhouse gas emission reduction targets boast the validation of the Science Based Targets Initiative (SBTi). Aligned with this target, the Company is resolutely aiming to curtail its Scope 1 and Scope 2 greenhouse gas emissions by 60 percent, and its Scope 3 emissions by 45 percent by 2030, measured against the baseline year 2020.
- The medication can be taken with or without food.
- Common side effects include headache and flushing.
- Consult your doctor before starting tadalafil 5mg.
News Abdi İbrahim Foundation Launches "Brave Strokes" Swimming Program for Children with Down SyndromeEstablished in 2021 by Abdi İbrahim, the healing power of Türkiye, the Abdi İbrahim Foundation aims to impart swimming skills to children aged 5 to 8 with Down Syndrome through the social responsibility project, Brave Strokes. This initiative is realized in collaboration with the Down Syndrome Association of Türkiye.Abdi İbrahim, the undisputed leader of the Turkish pharmaceutical industry for 22 years, has initiated a new project under the Abdi İbrahim Foundation, as part of its social investment programs that aim to create value for the country and society by healing the lives it touches. News Abdi İbrahim Publishes 6th Sustainability ReportConducting its sustainability operations with the vision of “Healing the Future,” Abdi İbrahim has released its 6th Sustainability Report, covering the tadalafil sale period of 2021-2022. The report includes Abdi İbrahim’s sustainability goals set for 2030, 2040, and 2050, within the framework of healing the future of the ecosystem, people and business, along with the projects carried out in line with these goals. Abdi İbrahim’s sustainability report offers a unique reading experience with digital artworks designed by artist Bager Akbay and his team, combining human imagination with artificial intelligence.Planning its sustainability activities with a comprehensive perspective encompassing environmental, social, and governance aspects, Abdi İbrahim published its 6th Sustainability Report, detailing its sustainability efforts between January 1, 2021 and December 31, 2022. News Abdi İbrahim Extends its Healing Touch to the GulfAbdi İbrahim forms a joint venture with Saudi Cigalah Healthcare, laying the foundation for expansion into Saudi Arabia and beyond, prioritizing exports as the initial step.Abdi İbrahim extends its healing touch to the Gulf News Abdi İbrahim, Türkiye's Leading Pharmaceutical Company, Extends its Ambitions Into Digital HealthAbdi İbrahim and CorPal unite to advance digital healthAs the unrivaled leader of the Turkish pharmaceutical industry for 22 years, Abdi İbrahim seeks to maximize the advantages of digital health solutions for both patients and healthcare professionals through a comprehensive partnership with CorPal, an AI-supported holistic rehabilitation platform.
2.2 Tadalafil Tablets for Once Daily Use for Erectile Dysfunction
News Abdi İbrahim and GSK Türkiye Make Major Investment for Domestic Production of Respiratory MedicineThe Sterile Inhalation Facility, jointly developed by Abdi İbrahim and GSK Türkiye in collaboration with the Investment Office of the Presidency of the Republic of Türkiye, commences operations.The facility, built with an investment of TRY 340 million, will enable Türkiye to benefit from the advanced ‘nebule’ technology, which is used in the treatment of respiratory diseases. The facility is the first in the world capable of manufacturing the complete range of GSK’s nebule portfolio. News The First "Mab" Biotech Pharmaceutical to be Locally Manufactured in Türkiye Will Bear the Mark of AbdiBio from the Cellular LevelANOTHER FIRST FROM ABDİ İBRAHİMAbdi İbrahim, the leader in the Turkish pharmaceutical industry for 21 years, continues its unwavering commitment to investing in biotechnology. Abdi İbrahim has announced a technology transfer agreement with the Spanish biosimilar developer, mAbxience, which is among the world’s leading companies in the field.Accordingly, a currently tadalafil for premature ejaculation imported cancer drug will now be manufactured by AbdiBio. Nezih Barut, Chairman of Abdi İbrahim, noted the technology transfer’s significance as the first “cell-to-end product” biotech pharmaceutical in Türkiye.
Does tadalafil interact with foods or drinks?
News Türkiye's Leading Pharmaceutical Company Expands its Portfolio and Presence in Consumer HealthABDİ İBRAHİM STRIKES DEAL WITH ARONPHARMAAbdi İbrahim, Türkiye's leading pharmaceutical company and a strong player in consumer health products, is collaborating with Aronpharma, a key European company specializing in innovative food supplements for their innovative brand Berroxin.Abdi İbrahim has acquired sales and distribution rights in Türkiye for products that help support the immune system under the Berroxin brand of Aronpharma, which offers innovative food supplement products. The portfolio will be launched in the Turkish market starting in 2023 with the assurance of Abdi İbrahim. News Abdi İbrahim Secures a Coveted Spot as the First Turkish Pharmaceutical Company on the CDP's Climate A ListThe unrivalled leader in the Turkish pharmaceutical industry for 22 years, Abdi İbrahim attains a noteworthy achievement by earning a coveted spot on the Climate A list within the 2023 Carbon Disclosure Project (CDP) Climate Change Program. For 112 years marked by a passion for progress, Abdi İbrahim has actively embraced the green transformation by diligently integrating environmental considerations into its business models. Aligned with the ambitious 1.5°C target of the Paris Agreement, its greenhouse gas emission reduction targets boast the validation of the Science Based Targets Initiative (SBTi). Through this collaboration, patients requiring long-term follow-up can access mental and physical rehabilitation anytime and anywhere.Abdi İbrahim, the healing power of Türkiye, has made a pioneering move in digital health through its collaboration with CorPal, an AI-supported holistic rehabilitation platform. Strengthening Abdi İbrahim's value-driven approach in the pharmaceutical industry and its technological leadership, this collaboration aims to develop innovative treatments, expand healthcare services, and provide solutions to help physicians improve patient care and monitoring.
1.1 Erectile Dysfunction
Emre Sakcı, our record-breaking national swimmer who will be representing Turkey in the Tokyo Olympics. Having signed a 4-year sponsorship agreement with H. Emre Sakcı, our record-holding athlete in national and international breaststroke, Abdi İbrahim Chairman Nezih Barut said "As Turkey's national and leading pharmaceutical company, we have decided to support athletes who have the potential to earn medals for our country by competing in swimming, one of the Olympic sports branch, in international contests and especially the Olympics. We have signed a long-term sponsorship agreement with Emre Sakcı who has stood out with his steady success in swimming and we will be his main sponsor for 4 years, including the Paris 2024 Olympics. We will continue our support to ensure that more Turkish athletes participate in the Olympics and thus achieve more victories for our country in the area of sports.
Before taking tadalafil,
"The unrivaled leader of the Turkish pharmaceutical industry for the last 19 years, Abdi İbrahim has once again broken new ground in the country's pharmaceutical industry by implementing a brand new social investment program that focuses on four main topics including "Health and Sports", "Social Innovation", "Raising Scientific Awareness in Youth" and "Volunteering Projects for Social Needs" with the aim of creating value in society by healing the lives we touch. In the framework of this program to be implemented as of 2021 with a long-term perspective, Abdi İbrahim has decided to support Emre Sakcı on his path to success with a four-year long-term sponsorship agreement in the scope of this program, the latter being one of the most important components of the company's sustainability strategy.Emre Sakcı started swimming at the age of three and was selected to the A National Team at 15. News Olympic Support to National Swimmer Emre SakcıOperating in the pharmaceutical industry for 109 years straight with the objective of healing life, Abdi İbrahim has become the main sponsor of H.
| Property | Description | Value/Notes |
|---|---|---|
| Active Ingredient | Tadalafil | 5 mg |
| Drug Class | Phosphodiesterase type 5 inhibitor | - |
| Half-life | 17.5 hours | Approximate |
| Bioavailability | ~80% | Oral administration |
| Absorption Time | 2 hours | Peak plasma concentration |
| Metabolism | Liver (via CYP3A4 enzyme) | - |
| Excretion | Feces (~61%), Urine (~36%) | - |
Emre Sakcı, our record-breaking national swimmer who will be representing Turkey in the Tokyo Olympics. Having signed a 4-year sponsorship agreement with H.
5.1 Cardiovascular
We see FEM certificate as a reward for our determined and continuous efforts in this field. Brochure HEALING THE LIVES, HEALING THE FUTURE THAT’S WHAT WE DO.Turkish pharmaceutical industry leader Abdi Ibrahim s journey began in 1912.In addition to its partnerships with more than 30 licensing firms across the globe, Abdi Ibrahim develops its own products with 250 brands and 500 products.Abdi Ibrahim has subsidiaries operating in 17 countries outside Turkey, exports to more than 70 countries from the European Union to Canada, North Africa to Asia and generates the highest employment rate in the Turkish pharmaceutical industry with 5500 qualified employees. News R&D Award to Abdi İbrahim in 5 CategoriesAbdi İbrahim, the uninterrupted leader of the Turkish pharmaceutical industry for 21 years, received awards in 5 categories at the Crystal Mortar Awards organized by the Chemists' Association.Acting for 111 years with the mission of improving life, Abdi İbrahim received awards in 5 categories at the Crystal Mortar Awards, given within the scope of the 11th International Pharmaceutical Chemistry Congress for its R&D studies and investments. On the opening day of the 11th International Pharmaceutical Chemistry Congress organized by the Chemists' Association in Antalya this year, the R&D activities of pharmaceutical companies were awarded in 7 categories. Abdi İbrahim won awards in 5 categories, including the “Pharmaceutical Company with the Most R&D Investments” category.
Product ACETYLSALICYLIC ACID /100 mg Enteric Coated Tablet
News Abdi İbrahim Foundation House of Kindness Open NowProviding accommodation for children and their families who come to Istanbul for cancer treatmentAbdi İbrahim, the leader of the Turkish pharmaceutical industry, has initiated a social project for children undergoing cancer treatment and their families. Abdi İbrahim Foundation House of Kindness, which provides accommodation for children who come to İstanbul for cancer treatment but face difficulties staying due to economic reasons, has opened its doors in Fatih, İstanbul. Speaking at the opening ceremony, Nesrin Barut Esirtgen, Deputy Chairperson of Abdi İbrahim and Chairperson of the Board of Trustees of the Abdi İbrahim Foundation, said: “Taking into account the accommodation needs of our children and their relatives who come to Istanbul for treatment, we realized the House of Kindness project to be part of the solution. We strongly believe that kindness and the passion for healing are contagious. Our House of Kindness is a reflection of this belief and will.” D.. Emre Sakcı, our record-holding athlete in national and international breaststroke, Abdi İbrahim Chairman Nezih Barut said "As Turkey's national and leading pharmaceutical company, we have decided to support athletes who have the potential to earn medals for our country by competing in swimming, one of the Olympic sports branch, in international contests and especially the Olympics. We have signed a long-term sponsorship agreement with Emre Sakcı who has stood out with his steady success in swimming and we will be his main sponsor for 4 years, including the Paris 2024 Olympics.
7.2 Potential for Other Drugs to Affect Tadalafil Tablets
Duration of action
We will continue our support to ensure that more Turkish athletes participate in the Olympics and thus achieve more victories for our country in the area of sports.
2.1 Tadalafil Tablets for Use as Needed for Erectile Dysfunction
Additional file 5: (download PDF )
"The unrivaled leader of the Turkish pharmaceutical industry for the last 19 years, Abdi İbrahim has once again broken new ground in the country's pharmaceutical industry by implementing a brand new social investment program that focuses on four main topics including "Health and Sports", "Social Innovation", "Raising Scientific Awareness in Youth" and "Volunteering Projects for Social Needs" with the aim of creating value in society by healing the lives we touch.
In case of emergency/overdose
Aligned with this target, the Company is resolutely aiming to curtail its Scope 1 and Scope 2 greenhouse gas emissions by 60 percent, and its Scope 3 emissions by 45 percent by 2030, measured against the baseline year 2020. News Abdi İbrahim Foundation Launches "Brave Strokes" Swimming Program for Children with Down SyndromeEstablished in 2021 by Abdi İbrahim, the healing power of Türkiye, the Abdi İbrahim Foundation aims to impart swimming skills to children aged 5 to 8 with Down Syndrome through the social responsibility project, Brave Strokes. This initiative is realized in collaboration with the Down Syndrome Association of Türkiye.Abdi İbrahim, the undisputed leader of the Turkish pharmaceutical industry for 22 years, has initiated a new project under the Abdi İbrahim Foundation, as part of its social investment programs that aim to create value for the country and society by healing the lives it touches. News Abdi İbrahim Publishes 6th Sustainability ReportConducting its sustainability operations with the vision of “Healing the Future,” Abdi İbrahim has released its 6th Sustainability Report, covering the tadalafil sale period of 2021-2022. The report includes Abdi İbrahim’s sustainability goals set for 2030, 2040, and 2050, within the framework of healing the future of the ecosystem, people and business, along with the projects carried out in line with these goals.
Tadalafil strengths
Abdi İbrahim’s sustainability report offers a unique reading experience with digital artworks designed by artist Bager Akbay and his team, combining human imagination with artificial intelligence.Planning its sustainability activities with a comprehensive perspective encompassing environmental, social, and governance aspects, Abdi İbrahim published its 6th Sustainability Report, detailing its sustainability efforts between January 1, 2021 and December 31, 2022. News Abdi İbrahim Extends its Healing Touch to the GulfAbdi İbrahim forms a joint venture with Saudi Cigalah Healthcare, laying the foundation for expansion into Saudi Arabia and beyond, prioritizing exports as the initial step.Abdi İbrahim extends its healing touch to the Gulf News Abdi İbrahim, Türkiye's Leading Pharmaceutical Company, Extends its Ambitions Into Digital HealthAbdi İbrahim and CorPal unite to advance digital healthAs the unrivaled leader of the Turkish pharmaceutical industry for 22 years, Abdi İbrahim seeks to maximize the advantages of digital health solutions for both patients and healthcare professionals through a comprehensive partnership with CorPal, an AI-supported holistic rehabilitation platform. Through this collaboration, patients requiring long-term follow-up can access mental and physical rehabilitation anytime and anywhere.Abdi İbrahim, the healing power of Türkiye, has made a pioneering move in digital health through its collaboration with CorPal, an AI-supported holistic rehabilitation platform. Strengthening Abdi İbrahim's value-driven approach in the pharmaceutical industry and its technological leadership, this collaboration aims to develop innovative treatments, expand healthcare services, and provide solutions to help physicians improve patient care and monitoring. News Olympic Support to National Swimmer Emre SakcıOperating in the pharmaceutical industry for 109 years straight with the objective of healing life, Abdi İbrahim has become the main sponsor of H. In the framework of this program to be implemented as of 2021 with a long-term perspective, Abdi İbrahim has decided to support Emre Sakcı on his path to success with a four-year long-term sponsorship agreement in the scope of this program, the latter being one of the most important components of the company's sustainability strategy.Emre Sakcı started swimming at the age of three and was selected to the A National Team at 15.
